{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:05:56Z","timestamp":1784696756264,"version":"3.55.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study aimed to develop and externally validate machine learning (ML) models for predicting lymph node metastasis (LNM) in patients with localized prostate cancer (PCa) using routinely available preoperative variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with localized PCa who underwent radical prostatectomy with extended pelvic lymph node dissection were retrospectively recruited from two institutions. The primary cohort comprised patients from the Affiliated Hospital of Qingdao University, while patients from the Third Affiliated Hospital of Soochow University were included as an external validation cohort. The primary cohort was randomly allocated into training (70%) and internal validation (30%) cohorts. Five ML algorithms were used to develop prediction models. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), and pairwise differences in AUC were assessed using DeLong\u2019s test. The optimal model was compared with the established Briganti and Memorial Sloan Kettering Cancer Center (MSKCC) nomograms. SHapley Additive exPlanations (SHAP) were utilized to enhance model interpretability and quantify the relative contribution of individual features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 632 patients were included in the primary cohort, and 395 patients were included in the external validation cohort. In the internal validation cohort, the LightGBM model significantly outperformed the other candidate ML algorithms (DeLong test, p &amp;lt; 0.05) and achieved an AUC of 0.8613 (95% CI: 0.7976-0.9251). In the external validation cohort, LightGBM maintained the highest AUC, reaching 0.8148 (95% CI: 0.7477-0.8819). Furthermore, the LightGBM model showed predictive performance comparable to that of the established Briganti and MSKCC nomograms. SHAP analysis demonstrated that total prostate-specific antigen, body mass index, biopsy gleason grade group, neutrophil-to-lymphocyte ratio, systematic prostate biopsy positive rate, neutrophil percentage-to-albumin ratio, clinical T stage, and platelet-to-lymphocyte ratio were the key contributors to the model\u2019s predictive performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The LightGBM model incorporating eight key variables achieved competitive performance and showed predictive ability comparable to that of established Briganti and MSKCC nomograms. This model may serve as a useful preoperative decision-support tool, although prospective validation in larger and more diverse populations is still required before routine clinical implementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1804019","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:45:49Z","timestamp":1784695549000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Using interpretable machine learning model to predict lymph node metastasis in patients with localized prostate cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Tianwei","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Urology, The Affiliated Hospital of Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfeng","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Urology, The Third Affiliated Hospital of Soochow University","place":["Changzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Urology, The Affiliated Hospital of Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruize","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Urology, The Affiliated Hospital of Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Urology, The Affiliated Hospital of Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxian","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, The Affiliated Hospital of Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinning","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, The Affiliated Hospital of Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jiao","sequence":"additional","affiliation":[{"name":"Department of Urology, The Affiliated Hospital of Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1590\/s1677-5538.ibju.2020.1063","article-title":"Pelvic lymph node dissection in high-risk prostate cancer","volume":"48","author":"Haiquel","year":"2022","journal-title":"Int Braz J Urol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1226366","article-title":"Role of lymphatic invasion in predicting biochemical recurrence after radical prostatectomy","volume":"13","author":"Chung","year":"2023","journal-title":"Front Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/1097-0142(20010101)91:1<66::aid-cncr9>3.0.co;2-p","article-title":"Risk of prostate carcinoma death in patients with lymph node metastasis","volume":"91","author":"Cheng","year":"2001","journal-title":"Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt120","article-title":"Extended pelvic lymph node dissection in prostate cancer: a 20-year audit in a single center","volume":"24","author":"Abdollah","year":"2013","journal-title":"Ann Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-011-0179-z","article-title":"Complications of pelvic lymph node dissection for prostate cancer","volume":"12","author":"Keegan","year":"2011","journal-title":"Curr Urol Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.21037\/tau-23-416","article-title":"Lymphoceles after pelvic lymph node dissection during robot-assisted radical prostatectomy","volume":"12","author":"Meenderink","year":"2023","journal-title":"Transl Androl Urol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2005.05.4767","article-title":"Detection of occult lymph node metastases in locally advanced node-negative prostate cancer","volume":"24","author":"Pagliarulo","year":"2006","journal-title":"J Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.10.044","article-title":"Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores","volume":"61","author":"Briganti","year":"2012","journal-title":"Eur Urol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.euros.2025.06.003","article-title":"Adaption of the Memorial Sloan Kettering Cancer Center nomograms for the prediction of prostate cancer-specific death in Sweden: a population-based cohort study","volume":"78","author":"Zelic","year":"2025","journal-title":"Eur Urol Open Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2007.05.022","article-title":"The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis","volume":"63","author":"H\u00f6vels","year":"2008","journal-title":"Clin Radiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2020.38.15_suppl.5502","article-title":"Diagnostic accuracy of 68Ga-PSMA-11 PET for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection: a multicenter prospective phase 3 imaging trial","volume":"7","author":"Hope","year":"2021","journal-title":"JAMA Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1186\/s12967-023-04318-w","article-title":"Development and validation of a clinic machine-learning nomogram for the prediction of risk stratifications of prostate cancer based on functional subsets of peripheral lymphocyte","volume":"21","author":"Yang","year":"2023","journal-title":"J Transl Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.5213\/inj.2346332.166","article-title":"Prediction of prostate cancer risk stratification based on a nonlinear transformation stacking learning strategy","volume":"28","author":"Cao","year":"2024","journal-title":"Int Neurourol J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"101870","DOI":"10.2139\/ssrn.4645887","article-title":"Development and validation of the utLIFE-PC algorithm for noninvasive detection of prostate cancer in urine: a prospective, observational study","volume":"5","author":"Han","year":"2024","journal-title":"Cell Rep Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/pros.70168","article-title":"Development of machine learning models for predicting prostate cancer in biopsy candidates using prostate-specific antigen, magnetic resonance imaging, and hematologic parameters","volume":"86","author":"\u00d6zl\u00fc","year":"2026","journal-title":"Prostate"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2147\/jmdh.s410301","article-title":"Machine learning and AI in cancer prognosis, prediction, and treatment selection: a critical approach","volume":"16","author":"Zhang","year":"2023","journal-title":"J Multidiscip Healthc"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1200\/cci.20.00072","article-title":"Machine learning in oncology: methods, applications, and challenges","volume":"4","author":"Bertsimas","year":"2020","journal-title":"JCO Clin Cancer Inform"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2022.10.021","article-title":"Oncologic outcomes of patients with lymph node invasion at prostatectomy and post-prostatectomy biochemical persistence","volume":"41","author":"Perera","year":"2023","journal-title":"Urol Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)38748-7","article-title":"Prognostic significance of lymph nodal metastases in prostate cancer","volume":"142","author":"Gervasi","year":"1989","journal-title":"J Urol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2020.08.005","article-title":"Management of patients with node-positive prostate cancer at radical prostatectomy and pelvic lymph node dissection: a systematic review","volume":"3","author":"Marra","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2006.01.043","article-title":"Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy","volume":"49","author":"Briganti","year":"2006","journal-title":"Eur Urol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/bju.15376","article-title":"External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imaging","volume":"128","author":"Soeterik","year":"2021","journal-title":"BJU Int"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2019.01.25","article-title":"Developing prediction models for clinical use using logistic regression: an overview","volume":"11","author":"Shipe","year":"2019","journal-title":"J Thorac Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2023.07.017","article-title":"Poor handling of continuous predictors in clinical prediction models using logistic regression: a systematic review","volume":"161","author":"Ma","year":"2023","journal-title":"J Clin Epidemiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1595000","article-title":"Inflammatory-based prognostic indicators in prostate cancer: evaluating NLR, PLR, and SII in relation to Cambridge and ISUP classifications","volume":"15","author":"Patrza\u0142ek","year":"2025","journal-title":"Front Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102984","article-title":"Inflammation as a driver of prostate cancer metastasis and therapeutic resistance","volume":"12","author":"Archer","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13321-023-00743-7","article-title":"Practical guidelines for the use of gradient boosting for molecular property prediction","volume":"15","author":"Boldini","year":"2023","journal-title":"J Cheminform"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.9b00633","article-title":"LightGBM: An effective and scalable algorithm for prediction of chemical toxicity-application to the Tox21 and mutagenicity data sets","volume":"59","author":"Zhang","year":"2019","journal-title":"J Chem Inf Model"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/485189","article-title":"Prognostic factors for the development of biochemical recurrence after radical prostatectomy","volume":"2011","author":"Kotb","year":"2011","journal-title":"Prostate Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/s0360-3016(04)01315-x","article-title":"Clinicopathologic analysis of extracapsular extension in prostate cancer: should the clinical target volume be expanded posterolaterally to account for microscopic extension","volume":"65","author":"Chao","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200105000-00014","article-title":"Primary Gleason pattern as a predictor of disease progression in Gleason score 7 prostate cancer: a multivariate analysis of 823 men treated with radical prostatectomy","volume":"25","author":"Herman","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1159\/000458763","article-title":"Clinical factors predicting and stratifying the risk of lymph node invasion in localized prostate cancer","volume":"99","author":"Porcaro","year":"2017","journal-title":"Urol Int"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25020856","article-title":"Preoperative factors for lymphovascular invasion in prostate cancer: a systematic review and meta-analysis","volume":"25","author":"Karwacki","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2018.11.020","article-title":"Prognostic role of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in prostate cancer: a meta-analysis of results from multivariate analysis","volume":"60","author":"Guo","year":"2018","journal-title":"Int J Surg"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70527","article-title":"The association between neutrophil-percentage-to-albumin ratio (NPAR) and mortality among individuals with cancer: insights from National Health and Nutrition Examination Survey","volume":"14","author":"Li","year":"2025","journal-title":"Cancer Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092079","article-title":"Prognostic role of NLR in urinary cancers: a meta-analysis","volume":"9","author":"Wei","year":"2014","journal-title":"PloS One"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158770","article-title":"Neutrophil-to-lymphocyte ratio predicts PSA response and prognosis in prostate cancer: a systematic review and meta-analysis","volume":"11","author":"Cao","year":"2016","journal-title":"PloS One"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000044730","article-title":"Association between neutrophil percentage-to-albumin ratio and prostate cancer: a cross-sectional study","volume":"104","author":"Jia","year":"2025","journal-title":"Med (Baltimore)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-021-00481-7","article-title":"Obesity and biochemical recurrence in clinically localised prostate cancer: a systematic review and meta-analysis of 86,490 patients","volume":"25","author":"Rivera-Izquierdo","year":"2022","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-020-0208-4","article-title":"Obesity-associated inflammation induces androgenic to estrogenic switch in the prostate gland","volume":"23","author":"Xue","year":"2020","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000127730.78973.fe","article-title":"The percent of biopsy cores positive for cancer is a predictor of advanced pathological stage and poor clinical outcomes in patients treated with radical prostatectomy","volume":"171","author":"Lotan","year":"2004","journal-title":"J Urol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1804019\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:45:51Z","timestamp":1784695551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1804019\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":43,"alternative-id":["10.3389\/fonc.2026.1804019"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1804019","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"article-number":"1804019"}}